AGP Picks
View all

My Africa News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.

Press releases published on October 22, 2026

48% of South Africans Anxious About AI as Teaching Emerges as a Resilient Career Option
Namib Minerals Signs Indicative US$30 Million Ecobank Term Sheet for Redwing Bankability Programme
Imperial Reports Red Chris Mine Block Cave Planning Progress and 2026 Third Quarter Production Update
Hercules Metals Announces $30 Million "Bought Deal" Private Placement of Common Shares
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
Dust-A-Side Turns Old Haul Road Material Into New Mine Roads
CaterKraft adds knee-operated hand wash basins for East Rand butcheries and takeaways
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
Ligand to Host Investor Day on December 8, 2026
Nordic Naturals Experts Share the Four Questions Every Consumer Should Ask About Their Supplements
InflaRx Highlights Izicopan’s Therapeutic Potential at  Kidney Week 2026
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
Atico Produces 2.08 Million Pounds of Cu and 2,472 Ounces of Au in Third Quarter 2026
RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
Critical Metals Corp. Merger with European Lithium Approved by European Lithium Securityholders
Vortex Energy Receives Government Approval for Ground Gravity Survey at Robinsons River Salt Project
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

My Africa News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.